• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Xalud Therapeutics prioritizes gene therapies, with ALS

    ENDPTS

    Xalud Therapeutics Presents Clinical Data on XT-150 in Knee Osteoarthritis

    GLOBENEWSWIRE

    Xalud Therapeutics CEO to Participate in Two Gene Therapy

    GLOBENEWSWIRE

    Xalud Tx Doses First Patient in Phase 2a Trial of XT-150 for Osteoarthritis Pain

    BUSINESSWIRE

    Xalud Receives FDA FTD for XT-150 in Pain Associated with Osteoarthritis

    BUSINESSWIRE

    Immunocore`s bispecific gets speedy review with FDA, EMA; Xalud grabs $30M

    ENDPTS

    Xalud Therapeutics’ XT-150, Achieves Multiple Clinical Milestones

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.